Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapyPanpan Zhang(Peking University), Yue Yang(Peking University)Cancer ScienceSeptember 1, 201610.1111/cas.13072Cited by 184SaveCiteExport RISWatch citationsRelated PapersBPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1|Theranostics|2018|56